Serum Institute likely to supply Corona Vaccine at ₹ 250 per dose

Serum Institute of India is close to signing a supply contract with the Centre and likely to fix prices at ₹ 250 per dose of the vaccine. The government is pinning its hopes for mass supply on Serum Institute, which lodged the first formal application for emergency-use approval of AstraZeneca’s shot on Monday.

Chief Executive Officer Adar Poonawalla had earlier said the vaccine would be priced at 1,000 rupees ($13.55) per dose in India’s private market, but governments signing large supply deals would likely buy it at lower prices.


Leave A Reply

Your email address will not be published.